Pump and Dump by Analysts before 100 Million dilution
Pump and Dump by Analysts
May 22 (Reuters) - Insmed Inc : * Canaccord Genuity raises price target to $17 from $12; rating buy
by levonchiko •May 22, 2013 7:43 PM .
increasing our price target to $18
Leerink Swann Bullish on Insmed (INSM); Raises PT to $22 (today $16.00)
by donper618 •May 23, 2013 4:31 AM .
Leerink Swann today maintained an Outperform rating on Insmed (NASDAQ: INSM) and raised its price target to $22.00 (from $13.00). Increased bullishness follows additional data on Arikace in cystic fibrosis (CF) and non-tuberculous mycobacteria (NFM).